Kevin J. Appelbaum - Chief Executive Officer, Director, 10%+ Owner at Better Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director, 10%+ Owner
Issuer Symbol
BTTX on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin J. Appelbaum since 05 Mar 2025

Holdings reported by Kevin J. Appelbaum for Better Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,406,719 $408,902 $0.1699 31 Mar 2022 By Trust
Common Stock 6,250 $1,062 $0.1699 31 Mar 2022 Direct
Stock Option (Right to Buy) 235,000 01 Apr 2022 Direct Common Stock

Transactions reported by Kevin J. Appelbaum for Better Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.